Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mucoprotein disulfide bonds are the critical covalent cross-links that stabilize the polymeric structure of respiratory mucins, specifically MUC5AC and MUC5B (Thornton et al., 2008, Annu Rev Physiol). These bonds are formed between cysteine-rich domains of mucin monomers, creating a high-molecular-weight network that determines the viscoelastic properties of airway mucus (Fahy & Dickey, 2010, N Engl J Med). In healthy individuals, this gel-like consistency is essential for the mucociliary escalator to trap and remove inhaled particles and pathogens. However, in diseases like cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD), the density of these disulfide bonds increases due to mucus hypersecretion and oxidative stress, leading to stagnant, thick mucus that obstructs the airways (Button et al., 2012, Science). Pharmacological targeting of these bonds is achieved through mucolytic agents like N-acetylcysteine (NAC), which possess a free sulfhydryl group that participates in a disulfide-sulfhydryl exchange reaction (Sadowska, 2012, Proc Am Thorac Soc). This reaction breaks the mucin polymers into smaller subunits, significantly reducing mucus viscosity and elasticity to facilitate clearance and improve respiratory function (Aldini et al., 2018, Free Radic Res).
Reduction of inter-mucin disulfide bridges via sulfhydryl-disulfide exchange, leading to the depolymerization of mucin networks and reduction of mucus viscosity (StatPearls, 2023; Sadowska, 2012).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mucoprotein disulfide bonds.